Producers face intense competition
As presented in the study World Enzymes, a new study from The Freedonia Group, developed countries have mature industrial markets with high levels of competition among enzyme manufacturers. In order to maintain and expand market share, manufacturers must continually improve their enzymes to offer efficient performance at lower temperatures or under more extreme pH conditions, lower costs through reduced energy and water usage, or higher quality end products and larger amounts of marketable co-products. This continued introduction of new enzyme formulations will fuel moderate growth in mature markets like food and beverages, cleaning products, and textiles and leather. Heightened interest in more niche applications, such as enzymatic production of protein hydrolysates for flavoring or protein supplementation, will also support growth in developed countries.
Rising healthcare costs to drive enzyme growth
Freedonia projects that specialty enzyme markets are expanding at a strong pace globally. Rising healthcare costs have led to the adoption of "personalized" medicine -- healthcare tailored to the individual based on their clinical profile, genetic background, and personal preferences -- by many providers. This approach to medicine requires the increased use of diagnostic testing as well as genomic sequencing, helping to drive strong demand for diagnostic enzymes. In developing countries, the number of diagnostic tests performed will increase as the number of insured individuals rises, further supporting growth in demand for the enzymes used in diagnostic testing. The competitive nature of the pharmaceutical industry will also lead to strong growth in specialty enzyme demand. Pharmaceutical companies will invest more in the development of biological pharmaceuticals, which will fuel demand for enzymes used in research and biotechnology. In addition, pharmaceutical companies will increasingly utilize biocatalysts to reduce the cost of pharmaceutical manufacturing and make non-generic drugs more cost-competitive.
World Enzymes presents historical data (2005, 2010 and 2015) plus forecasts (2020 and 2025) for supply and demand, as well as demand by type and market, in 6 regions and 15 countries. This study also considers key market environment factors, evaluates company market share and profiles 20 global competitors.
Freedonia's market research studies provide timely access to reliable, unbiased analysis from which to benchmark performance and answer critical questions: Is your business growing faster or slower than the overall market? Is your organization gaining or losing market share? Which products and markets are the most desirable to explore for expansion? Are there industry trends or competitor activities that present a threat or opportunity to your business?
Studies offer a great ROI and can help business leaders make informed, analytically driven decisions. When considering the time, effort, and expertise that goes into it, our off-the-shelf research saves our clients time and money.
Download the full report: https://www.reportbuyer.com/product/747897/
About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/world-enzymes-market-300375858.html